UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Annals of oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue 7, pp. vii131 - vii138
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms, Hormone-Dependent - diagnosis | Risk Assessment | Pheochromocytoma - diagnosis | Adrenocortical Carcinoma - secondary | Humans | Adrenocortical Carcinoma - diagnosis | Chemoradiotherapy, Adjuvant | Adrenocortical Carcinoma - therapy | Mitotane - therapeutic use | Adrenal Gland Neoplasms - diagnosis | Adrenalectomy | Neoplasms, Hormone-Dependent - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Pheochromocytoma - secondary | Neoplasm Staging | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - pathology | Adrenal Gland Neoplasms - therapy | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2020, Volume 31, Issue 11, pp. 1476 - 1490
SURVIVAL | treatment | ADJUVANT MITOTANE | MANAGEMENT | diagnosis | PARAGANGLIOMA | EUROPEAN-SOCIETY | CHEMOTHERAPY | follow-up | PHASE-II TRIAL | THERAPY | Clinical Practice Guidelines | adrenal cancer | SKELETAL-RELATED EVENTS | METASTATIC PHEOCHROMOCYTOMAS | Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 03/2015, Volume 100, Issue 3, pp. 841 - 849
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Predictive Value of Tests | Prognosis | Adrenocortical Carcinoma - surgery | Humans | Middle Aged | Adrenocortical Carcinoma - diagnosis | Child, Preschool | Infant | Ki-67 Antigen - metabolism | Male | Young Adult | Adrenal Cortex Neoplasms - diagnosis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Adrenocortical Carcinoma - mortality | Child | Adrenal Cortex Neoplasms - mortality | Adrenal Cortex Neoplasms - surgery | Treatment Outcome | Adrenalectomy | Adolescent | Survival Analysis | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 2019, Volume 92, pp. e83 - e95
Journal Article
European journal of endocrinology, ISSN 0804-4643, 09/2013, Volume 169, Issue 3, pp. 263 - 270
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Adrenal Cortex Neoplasms - blood | Follow-Up Studies | Adrenocortical Carcinoma - surgery | Humans | Middle Aged | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Young Adult | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Retrospective Studies | Adrenal Cortex - drug effects | Chemotherapy, Adjuvant | Adrenal Cortex Neoplasms - prevention & control | Neoplasm Recurrence, Local - prevention & control | Adrenal Cortex Neoplasms - surgery | Mitotane - adverse effects | Adrenocortical Carcinoma - prevention & control | Mitotane - therapeutic use | Adrenal Cortex - surgery | Mitotane - pharmacokinetics | Antineoplastic Agents, Hormonal - blood | Adrenal Cortex Neoplasms - drug therapy | Mitotane - blood | Adolescent | Survival Analysis | Aged | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4759 - 4767
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Adrenals. Adrenal axis. Renin-angiotensin system (diseases) | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Vertebrates: endocrinology | Malignant tumors | Biological and medical sciences | Endocrinopathies | Medical sciences | Dichlorodiphenyl Dichloroethylene - blood | Adrenal Cortex Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gastrointestinal Diseases - physiopathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Dose-Response Relationship, Drug | Adrenocortical Carcinoma - pathology | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Drug Interactions | Antineoplastic Agents, Hormonal - therapeutic use | Biotransformation | Adult | Female | Adrenal Cortex - drug effects | Mitotane - administration & dosage | Severity of Illness Index | Adrenocortical Carcinoma - secondary | Antineoplastic Agents, Hormonal - administration & dosage | Mitotane - adverse effects | Adrenal Cortex Neoplasms - pathology | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neurotoxicity Syndromes - physiopathology | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Gastrointestinal Diseases - chemically induced | Phenylacetates - blood | Index Medicus | Abridged Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 2020, Volume 105
Journal Article
Thyroid (New York, N.Y.), ISSN 1050-7256, 10/2013, Volume 23, Issue 10, pp. 1247 - 1255
Thyroid Cancer and Nodules | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Depression - physiopathology | Prevalence | Thyroid Neoplasms - psychology | Humans | Middle Aged | Netherlands - epidemiology | Cost of Illness | Fatigue - etiology | Male | Neuromuscular Diseases - physiopathology | Depression - etiology | Thyroid Neoplasms - therapy | Cognition Disorders - etiology | Stress, Psychological - epidemiology | Anxiety - epidemiology | Adult | Female | Registries | Survivors - psychology | Severity of Illness Index | Cognition Disorders - physiopathology | Depression - epidemiology | Cross-Sectional Studies | Anxiety - physiopathology | Combined Modality Therapy - adverse effects | Thyroid Neoplasms - physiopathology | Fatigue - epidemiology | Fatigue - physiopathology | Quality of Life | Aged | Neuromuscular Diseases - etiology | Neuromuscular Diseases - epidemiology | Cognition Disorders - epidemiology | Anxiety - etiology | Stress, Psychological - etiology | Cohort Studies | Stress, Psychological - physiopathology | Index Medicus
Journal Article
Clinical endocrinology (Oxford), ISSN 0300-0664, 2011, Volume 75, Issue 4, pp. 544 - 554
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Non tumoral diseases. Target tissue resistance. Benign neoplasms | Vertebrates: endocrinology | Malignant tumors | Thyroid. Thyroid axis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Thyroid Neoplasms - physiopathology | Thyroid Neoplasms - therapy | Thyroid Neoplasms - drug therapy | Humans | Quality of Life | Female | Male | Cancer survivors | Care and treatment | Ablation (Surgery) | Thyroid cancer | Oncology, Experimental | Glycoproteins | Research | Hormones | Cancer | Quality of life | Index Medicus
Journal Article
Acta oncologica, ISSN 0284-186X, 02/2013, Volume 52, Issue 2, pp. 249 - 258
Life Sciences & Biomedicine | Oncology | Science & Technology | Thyroid Neoplasms - mortality | Thyroid Neoplasms - psychology | Humans | Middle Aged | Survivors - statistics & numerical data | Male | Disease Progression | Thyroid Neoplasms - physiopathology | Registries - statistics & numerical data | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Survivors - psychology | Health Status | Thyroid Neoplasms - pathology | Index Medicus
Journal Article
Diabetes & metabolism, ISSN 1262-3636, 2018, Volume 44, Issue 1, pp. 22 - 29
GLYCEMIC CONTROL | Glucose-lowering drugs | MEDICATIONS | METAANALYSIS | RISK | MELLITUS | ADHERENCE | Treatment changes | INSULIN-USE | THERAPY | START | Diabetes | Cancer
Journal Article
Diabetologia, ISSN 0012-186X, 2015, Volume 58, Issue 6, pp. 1380 - 1381
Journal Article
Diabetologia, ISSN 0012-186X, 01/2012, Volume 55, Issue 1, pp. 51 - 62
Insulin analogues | Breast cancer | Insulin glargine | Insulin | Cancer | Medicine & Public Health | Human Physiology | Metabolic Diseases | Internal Medicine | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Tumors | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Patient Admission | Male | Risk | Incidence | Dose-Response Relationship, Drug | Neoplasms - complications | Neoplasms - chemically induced | Hypoglycemic Agents - administration & dosage | Community Pharmacy Services | Female | Insulin - analogs & derivatives | Medical Record Linkage | Diabetes Mellitus, Type 2 - complications | Breast Neoplasms - epidemiology | Hypoglycemic Agents - therapeutic use | Proportional Hazards Models | Insulin, Regular, Human - adverse effects | Insulin - administration & dosage | Insulin, Regular, Human - therapeutic use | Insulin, Regular, Human - administration & dosage | Breast Neoplasms - complications | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Breast Neoplasms - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Electronic Health Records | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Neoplasms - epidemiology | Cohort Studies | Heterocyclic compounds | Oncology, Experimental | Research | Risk factors | Public health | Medical informatics | Index Medicus
Journal Article